High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma

Cyclin-dependent kinase regulatory subunit 2 (CKS2) is a potential prognostic marker and is overexpressed in various cancers. This study analyzed sequencing and clinical data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus, with external validation using the Chinese Glioma Genome Atl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Kai, Ji, Yulong, Liu, Min, Shen, Fugeng, Xiong, Xiaoxing, Gu, Lijuan, Lu, Tianzhu, Ye, Yingze, Feng, Shi, He, Jianying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160311/
https://www.ncbi.nlm.nih.gov/pubmed/35663965
http://dx.doi.org/10.3389/fimmu.2022.881453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160311/
https://www.ncbi.nlm.nih.gov/pubmed/35663965
http://dx.doi.org/10.3389/fimmu.2022.881453

Ejemplares similares